A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma

Marilena De Mariano, Sara Stigliani, Stefano Moretti, Federica Parodi, Michela Croce, Cinzia Bernardi, Aldo Pagano, Gian Paolo Tonini, Silvano Ferrini, Luca Longo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The discovery of missense mutations of ALK gene identified this receptor tyrosine kinase as a therapeutic target in neuroblastoma (NB). Moreover, a high level of ALK protein has been associated with metastatic NB cases and with a worse prognosis, suggesting that also ALK overexpression is involved in NB tumorigenesis. Since miRNAs play key roles in the regulation of gene expression we aimed at identifying those miRNAs that can regulate ALK in NB. We therefore analyzed the genome-wide expression profile of miRNAs in two sample sets of 16 NB cell lines and 22 NB samples by using miRNA microarrays. Both sample sets were then divided into two subgroups showing high (ALK+) or low/absent (ALK-) expression of ALK. Results showed a down-regulation of 30 and 23 miRNAs (p-value < 0.05) in the ALK+ group in NB cell lines and samples, respectively. Validation analysis indicated that miR-424-5p and miR-503-5p, belonging to the same cluster, were differentially expressed in both NB cell lines and tumor samples. Although only miR-424-5p showed a direct binding to ALK 3'-UTR, both miRNAs led to a remarkable decreasing of ALK protein as well as to the inhibition of cell viability in ALK+ NB cell lines. In conclusion, our data indicate that both miR-424-5p and miR-503-5p are involved in regulating ALK expression in NB, either by directly targeting ALK receptor or indirectly, and may thus serve as potential therapeutic tools in ALK dependent NBs.

Original languageEnglish
Pages (from-to)56518-56532
Number of pages15
JournalOncotarget
Volume8
Issue number34
DOIs
Publication statusPublished - 2017

Fingerprint

MicroRNAs
Neuroblastoma
Genome
Cell Line
Gene Expression Regulation
Receptor Protein-Tyrosine Kinases
3' Untranslated Regions
Missense Mutation
Tumor Cell Line
Cell Survival
Carcinogenesis
Proteins
Down-Regulation
Therapeutics

Keywords

  • ALK
  • MicroRNA
  • MiR-424-5p
  • MiR-503-5p
  • Neuroblastoma

ASJC Scopus subject areas

  • Oncology

Cite this

De Mariano, M., Stigliani, S., Moretti, S., Parodi, F., Croce, M., Bernardi, C., ... Longo, L. (2017). A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma. Oncotarget, 8(34), 56518-56532. https://doi.org/10.18632/oncotarget.17033

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma. / De Mariano, Marilena; Stigliani, Sara; Moretti, Stefano; Parodi, Federica; Croce, Michela; Bernardi, Cinzia; Pagano, Aldo; Tonini, Gian Paolo; Ferrini, Silvano; Longo, Luca.

In: Oncotarget, Vol. 8, No. 34, 2017, p. 56518-56532.

Research output: Contribution to journalArticle

De Mariano, M, Stigliani, S, Moretti, S, Parodi, F, Croce, M, Bernardi, C, Pagano, A, Tonini, GP, Ferrini, S & Longo, L 2017, 'A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma', Oncotarget, vol. 8, no. 34, pp. 56518-56532. https://doi.org/10.18632/oncotarget.17033
De Mariano, Marilena ; Stigliani, Sara ; Moretti, Stefano ; Parodi, Federica ; Croce, Michela ; Bernardi, Cinzia ; Pagano, Aldo ; Tonini, Gian Paolo ; Ferrini, Silvano ; Longo, Luca. / A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma. In: Oncotarget. 2017 ; Vol. 8, No. 34. pp. 56518-56532.
@article{6d7a6f38aafb495da72649855ff5306c,
title = "A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma",
abstract = "The discovery of missense mutations of ALK gene identified this receptor tyrosine kinase as a therapeutic target in neuroblastoma (NB). Moreover, a high level of ALK protein has been associated with metastatic NB cases and with a worse prognosis, suggesting that also ALK overexpression is involved in NB tumorigenesis. Since miRNAs play key roles in the regulation of gene expression we aimed at identifying those miRNAs that can regulate ALK in NB. We therefore analyzed the genome-wide expression profile of miRNAs in two sample sets of 16 NB cell lines and 22 NB samples by using miRNA microarrays. Both sample sets were then divided into two subgroups showing high (ALK+) or low/absent (ALK-) expression of ALK. Results showed a down-regulation of 30 and 23 miRNAs (p-value < 0.05) in the ALK+ group in NB cell lines and samples, respectively. Validation analysis indicated that miR-424-5p and miR-503-5p, belonging to the same cluster, were differentially expressed in both NB cell lines and tumor samples. Although only miR-424-5p showed a direct binding to ALK 3'-UTR, both miRNAs led to a remarkable decreasing of ALK protein as well as to the inhibition of cell viability in ALK+ NB cell lines. In conclusion, our data indicate that both miR-424-5p and miR-503-5p are involved in regulating ALK expression in NB, either by directly targeting ALK receptor or indirectly, and may thus serve as potential therapeutic tools in ALK dependent NBs.",
keywords = "ALK, MicroRNA, MiR-424-5p, MiR-503-5p, Neuroblastoma",
author = "{De Mariano}, Marilena and Sara Stigliani and Stefano Moretti and Federica Parodi and Michela Croce and Cinzia Bernardi and Aldo Pagano and Tonini, {Gian Paolo} and Silvano Ferrini and Luca Longo",
year = "2017",
doi = "10.18632/oncotarget.17033",
language = "English",
volume = "8",
pages = "56518--56532",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "34",

}

TY - JOUR

T1 - A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma

AU - De Mariano, Marilena

AU - Stigliani, Sara

AU - Moretti, Stefano

AU - Parodi, Federica

AU - Croce, Michela

AU - Bernardi, Cinzia

AU - Pagano, Aldo

AU - Tonini, Gian Paolo

AU - Ferrini, Silvano

AU - Longo, Luca

PY - 2017

Y1 - 2017

N2 - The discovery of missense mutations of ALK gene identified this receptor tyrosine kinase as a therapeutic target in neuroblastoma (NB). Moreover, a high level of ALK protein has been associated with metastatic NB cases and with a worse prognosis, suggesting that also ALK overexpression is involved in NB tumorigenesis. Since miRNAs play key roles in the regulation of gene expression we aimed at identifying those miRNAs that can regulate ALK in NB. We therefore analyzed the genome-wide expression profile of miRNAs in two sample sets of 16 NB cell lines and 22 NB samples by using miRNA microarrays. Both sample sets were then divided into two subgroups showing high (ALK+) or low/absent (ALK-) expression of ALK. Results showed a down-regulation of 30 and 23 miRNAs (p-value < 0.05) in the ALK+ group in NB cell lines and samples, respectively. Validation analysis indicated that miR-424-5p and miR-503-5p, belonging to the same cluster, were differentially expressed in both NB cell lines and tumor samples. Although only miR-424-5p showed a direct binding to ALK 3'-UTR, both miRNAs led to a remarkable decreasing of ALK protein as well as to the inhibition of cell viability in ALK+ NB cell lines. In conclusion, our data indicate that both miR-424-5p and miR-503-5p are involved in regulating ALK expression in NB, either by directly targeting ALK receptor or indirectly, and may thus serve as potential therapeutic tools in ALK dependent NBs.

AB - The discovery of missense mutations of ALK gene identified this receptor tyrosine kinase as a therapeutic target in neuroblastoma (NB). Moreover, a high level of ALK protein has been associated with metastatic NB cases and with a worse prognosis, suggesting that also ALK overexpression is involved in NB tumorigenesis. Since miRNAs play key roles in the regulation of gene expression we aimed at identifying those miRNAs that can regulate ALK in NB. We therefore analyzed the genome-wide expression profile of miRNAs in two sample sets of 16 NB cell lines and 22 NB samples by using miRNA microarrays. Both sample sets were then divided into two subgroups showing high (ALK+) or low/absent (ALK-) expression of ALK. Results showed a down-regulation of 30 and 23 miRNAs (p-value < 0.05) in the ALK+ group in NB cell lines and samples, respectively. Validation analysis indicated that miR-424-5p and miR-503-5p, belonging to the same cluster, were differentially expressed in both NB cell lines and tumor samples. Although only miR-424-5p showed a direct binding to ALK 3'-UTR, both miRNAs led to a remarkable decreasing of ALK protein as well as to the inhibition of cell viability in ALK+ NB cell lines. In conclusion, our data indicate that both miR-424-5p and miR-503-5p are involved in regulating ALK expression in NB, either by directly targeting ALK receptor or indirectly, and may thus serve as potential therapeutic tools in ALK dependent NBs.

KW - ALK

KW - MicroRNA

KW - MiR-424-5p

KW - MiR-503-5p

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=85029072160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029072160&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.17033

DO - 10.18632/oncotarget.17033

M3 - Article

VL - 8

SP - 56518

EP - 56532

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -